Envoy Medical Inc.

COCH | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.73

+$0.02 (+2.74%)

Sep 22, 2026, 2:37 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.74%

(1D)

Rating

Updated: Aug 29, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $15.12M

1D Range

0.70 0.73

52W Range

0.36 1.89

Valuation (TTM)

PE -1.06

PB 4.47

EV/EBITDA 0.18

Valuation (NTM)

Forward PE N/A

Forward PEG 0.04

Price Target $2

Cash Flow

FCF Yield -146.9%

SBC Adj. FCF Yield -150.9%

SBC Impact -2.7%

Margins

Gross Margin -385.5%

Operating Margin -11411.1%

FCF Margin -10488.4%

Growth (CAGR)

Revenue 3Y | 5Y -1.7% | 4.4%

Dil EPS 3Y | 5Y 9.9% | 0.0%

FCF 3Y | 5Y -0.5% | -22.5%

Returns

ROA -97.7%

ROE 1719.7%

ROIC -206.3%

Financial Health

Net Cash

$19.68M

Current Ratio 1.73

Interest Coverage -50.15

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional ...

Sector Healthcare

Industry Medical - Devices

Employees 43

IPO Date Apr 28, 2021

Website www.envoymedical.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+173.97%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞